EGFR and non-small cell lung carcinoma: Taking into account that the activating EGFR mutations are considered an early clonal somatic event in NSCLC development2,14 we assumed their presence at a clonal level within the tumour and related the T790M VAF to the activating EGFR mutation VAF in order to calculate T790M subclonality.